Showing results (321-330 of 553) with videos related to

Sort By:
Pageof 56
The Journal of Pharmacology and Experimental Therapeutics|March 1, 1996
Enantioselective inotropic actions of the Na+-channel activators BDF 9148, BDF 9196 and BDF 9167 in human failing and nonfailing myocardiumR H Schwinger, J Müller-Ehmsen, M Böhm, et al.
Biochimica Et Biophysica Acta|April 10, 1980
Effects of vanadate in cultured rat heart muscle cells. Vanadate transport, intracellular binding and vanadate-induced changes in beating and in active cation fluxK Werdan, G Bauriedel, M Bozsik, et al.
Deutsche Medizinische Wochenschrift (1946)|February 19, 2011
[Hemodynamic monitoring in the intensive care unit: pulmonary artery catheter versus PiCCO]N Gassanov, E Caglayan, A Nia, et al.
American Heart Journal|August 1, 1992
Existence of PAF receptors in human platelets and human lung tissue but not in the human myocardiumR H Schwinger, M Böhm, K La Rosée, et al.
Basic Research in Cardiology|May 1, 1980
Significance of NADH-vanadate-oxidoreductase of cardiac and erythrocyte cell membranesE Erdmann, K Werdan, W Krawietz, et al.
Deutsche Medizinische Wochenschrift (1946)|February 9, 2011
[Epileptic seizures: effects on cardiac function]L Burghaus, G R Fink, E Erdmann, et al.
Der Internist|October 21, 2003
[A 41 year-old male patient with fever of unknown origin and bacteremia with actinobacillus actinomycetemcomitans]S Rosenkranz, K Töpelt, H Seifert, et al.
Biochemical Pharmacology|December 1, 1982
Effect of vanadium in the +5, +4 and +3 oxidation states on cardiac force of contraction, adenylate cyclase and (Na+ + K+)-ATPase activityW Schmitz, H Scholz, E Erdmann, et al.
Hypertension (Dallas, Tex. : 1979)|May 1, 1995
Treatment in hypertensive cardiac hypertrophy, II. Postreceptor eventsM Böhm, C Gräbel, M Flesch, et al.
The Clinical Investigator|July 1, 1993
Percutaneous transluminal coronary angioplasty of focal coronary lesions after cardiac transplantationW von Scheidt, B M Kemkes, B Reichart, et al.
Pageof 56